US sinks another $2.1 billion into a potential vaccine

US sinks another $2.1 billion into a potential vaccine

Seattle Times

Published

LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes something will work. The United States will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery of […]

Full Article